000			01421 a2200397 4500
005			20250518063016.0
264		0	_c20200406
008			202004s 0 0 eng d
022			_a1471-8391
024	7		_a10.1093/bmb/ldz031 _2doi
040			_aNLM _beng _cNLM
100	1		_aKrishna, B A
245	0	0	_aAdvances in the treatment of cytomegalovirus. _h[electronic resource]
260			_bBritish medical bulletin _c09 2019
300			_a5-17 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntiviral Agents _xpharmacology
650	0	4	_aCytomegalovirus _xphysiology
650	0	4	_aCytomegalovirus Infections _xcongenital
650	0	4	_aCytomegalovirus Vaccines
650	0	4	_aDrug Development
650	0	4	_aEarly Diagnosis
650	0	4	_aHematopoietic Stem Cell Transplantation _xadverse effects
650	0	4	_aHumans
650	0	4	_aImmunity, Cellular _xphysiology
650	0	4	_aImmunoglobulins _xtherapeutic use
650	0	4	_aImmunosuppression Therapy _xadverse effects
650	0	4	_aInfant, Newborn
650	0	4	_aOrgan Transplantation _xadverse effects
650	0	4	_aPerinatal Care
650	0	4	_aVirus Latency _xdrug effects
700	1		_aWills, M R
700	1		_aSinclair, J H
773	0		_tBritish medical bulletin _gvol. 131 _gno. 1 _gp. 5-17
856	4	0	_uhttps://doi.org/10.1093/bmb/ldz031 _zAvailable from publisher's website
999			_c30170196 _d30170196